|
[Press Release]
Annoucement of ASAHI INTECC CO., LTD on Fielder XT-A and Fielder XT-R PTCA guidewires launch in Europe and parts of Asia
Friday 17th May, 2013
|
|
[Press Release]
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Thursday 16th May, 2013
|
|
[Press Release]
Sorin Group annouces FDA approval and U.S launch of smartview (tm) remote monitoring solution for patients with implanted cardiac defibrillators
Monday 13th May, 2013
|
|
[Press Release]
Landmark study demonstrates lower rate of inappropriate shocks in patients with Sorin Dual Chamber ICD devices
Late-Breaking data presented at Heart Rhythm Society’s 2013 Annual Meeting show benefits compared with single chamber devices sustained in long-term follow-up
Monday 13th May, 2013
|
|
[Press Release]
Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life in AV Block Patients with Heart Failure and Reduced Pumping Function
(Thomson Reuters ONE via COMTEX) --New Medtronic Data Show Additional Clinical Advantages in Pacing Both Ventricles Versus Conventional Right-Ventricular Pacing
Saturday 11th May, 2013
|
|
[Press Release]
Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years
Industry-Leading Battery Life Reduces the Frequency of Replacement Surgery
Friday 10th May, 2013
|
|
[Press Release]
Boston Scientific Receives CE Mark Approval For The Rhythmia™ Mapping System
Company Offers Mapping System with IntellaMap Orion™ Mapping Catheter in Effort to Significantly Enhance Physician Treatment Options
Friday 10th May, 2013
|
|
[Press Release]
Data Show Medtronic-Exclusive LIA Software Detects Non-Medtronic Lead Issues at a Greater Rate Than Standard Impedance Monitoring
Friday 10th May, 2013
|
|
[Press Release]
New Research Demonstrates Success of Shock Avoidance in Medtronic Defibrillators
"Shock-Less" Late Breaking Clinical Trial: Providing Clinicians with ICD Programming Reports Improves Adherence to Evidence-Based Guidelines, Reduces All-Cause Shocks PainFree SST Trial: More Than 98 Percent of Patients with SmartShock(TM) Technology Are Free of Inappropriate Shock at One YearADVANCE III Trial: Waiting to Deliver ICD Therapy Combined with ATP During...
Friday 10th May, 2013
|
|
[Press Release]
St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013
Population Health Research Institute analysis continues to demonstrate strong safety and reliability of Optim-insulated leads
Thursday 9th May, 2013
|